Centogene NVNASDAQ:CNTGNASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)
- LAST PRICE0.4799
- TODAY'S CHANGE (%)0.0189 (4.0998%)
- Bid / Lots0.4410/ 12
- Ask / Lots0.4884/ 1
- Open / Previous Close0.4500 / 0.4610
- Day Range
- 52 Week Range
- Volume7,168
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CNTG |
|---|---|---|
| 09:32 ET | 150 | 0.45 |
| 10:55 ET | 100 | 0.45 |
| 11:18 ET | 4360 | 0.45 |
| 11:26 ET | 100 | 0.4491 |
| 12:21 ET | 800 | 0.4408 |
| 01:33 ET | 200 | 0.4408 |
| 03:05 ET | 100 | 0.45 |
| 03:59 ET | 536 | 0.4799 |
Apr 2, 2024
CENTOGENE Receives Nasdaq Non-Compliance Notice, from 4:30PM ET on Tuesday Apr 02, 2024 by Dow Jones
4:30PM ET on Tuesday Apr 02, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Centogene NV | 12.8M | -0.3x | --- |
Molecular Templates Inc | 10.8M | -1.0x | --- |
Neptune Wellness Solutions Inc | 226.6K | 0.0x | --- |
MEI Pharma Inc | 21.7M | 1.0x | --- |
RVL Pharmaceuticals PLC | 110.0 | 0.0x | --- |
Sorrento Therapeutics Inc | 11.0M | 0.0x | --- |
Company Information
Centogene N.V., is a commercial company. The company focuses on rare diseases, transforming clinical and genetic data into actionable information for patients, physicians and pharmaceutical companies. The company's platform includes epidemiological, phenotypic, and genetic data reflecting a global population, as well as a biobank of blood samples from these patients. The company's pharmaceutical segment provides a variety of services to its pharmaceutical partners, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring. The Company's Clinical Diagnostics segment provides targeted genetic sequencing and diagnostic services to patients through its distribution partners and customers, which are typically physicians, laboratories or hospitals.
Contact Information
- Headquarters
- Am Strande 7ROSTOCK, Germany 18055
- Phone
- ---
- Fax
- ---
Executives
- Independent Chairman of the Supervisory Board
- Peer Schatz
- Chief Executive Officer, Managing Director
- Kim Stratton
- Vice Chairman of the Supervisory Board
- Andreas Busch
- Chief Financial Officer - Legal & IT
- Jose Rios
- Chief Scientific Officer
- Patrice Denefle
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $12.8M |
|---|---|
Revenue (TTM) | $54.2M |
Shares Outstanding | 27.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.71 |
EPS | $-1.57 |
Book Value | $0.29 |
P/E Ratio | -0.3x |
Price/Sales (TTM) | 0.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -72.25% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
